JACOB MANDEL to Reproducibility of Results
This is a "connection" page, showing publications JACOB MANDEL has written about Reproducibility of Results.
Connection Strength
0.113
-
Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma. Neuro Oncol. 2018 01 10; 20(1):113-122.
Score: 0.091
-
Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients. J Neurooncol. 2017 Oct; 135(1):75-81.
Score: 0.022